secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001493152-25-003977
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell completes 15:1 share consolidation to comply with Nasdaq listing
-------------------------------------------------------------------------

- Consolidation effective Jan 24, 2025; post-consolidation shares begin trading Jan 29, 2025.
- Shares reduced from 44,204,061 to 2,946,940; no fractional shares issued.
- New CUSIP: 107930208; tickers BCTX and BCTXW unchanged on Nasdaq and TSX.
- Exercise prices and conversion ratios on convertible securities proportionately adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225003977/0001493152-25-003977-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225003977/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003977

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer